Who’s Running The US FDA? Interim Team May Not Have Assumed Control

White House expected to name Sara Brenner, chief medical officer for in vitro diagnostics at CDRH and a veteran of first Trump administration, as acting commissioner, but lack of a formal announcement is creating uncertainty. New executive orders on telework and the senior executive service also could impact agency staff.

The FDA's leadership profiles web page is missing entries for the top two posts. (Screenshot)

More from Policy & Regulation

More from HBW Insight